Workshops and Symposia

Symposium on Translational Hematology: Towards Chemo-Free Therapy in Hematologic Malignancies

Thursday, 27 August, 13:00-16:45 CEST | Free

Location: Lecture Room HZ4

This free symposium is designed for a translational/clinical audience, spanning discovery scientists to practicing clinician scientists.

Highlighting innovation, unmet need, and the shared goal of moving toward safer, more effective, chemo free care.

Bringing together academic innovators and clinical experts at the forefront of therapeutic development.

Translational hematology: Towards chemo free therapy in hematologic malignancies is a satellite symposium focused on the latest developments in targeted treatment strategies for a range of blood cancers. The program will showcase how advances in molecular genetics, cell signaling, immune modulation, and disease biology are translating into durable, chemo free therapeutic options.

The ISEH meeting setting offers a high value forum with a scientifically rigorous audience shaping the future of hematology. Structured around disease focused segments—lymphoid malignancies; acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS); and myeloproliferative neoplasms—the symposium will feature recognized thought leaders discussing clinical outcomes, resistance mechanisms, and rational combination strategies.

Translational Hematology: Towards Chemo Free Therapy in Hematologic Malignancies
Time	Program
12:30 - 13:00	Exhibitor Hours
13:00 - 13:05	Opening Remarks
Session 1
13:05 - 13:35	FLT3i beyond FLT3-AML: Explore the evolving role of FLT3 inhibitors in newly diagnosed AML Rebeca Rodriguez, MD, Instituto de Investigación Sanitaria La Fe, Valencia, Spain Sponsored by:
13:35 - 14:05	Symposium to be announced.
14:10 - 14:40	Targeted Therapy in AML – IDH1 as an Example for Bench and Bedside Lars Bullinger, MD, Charité Universitätsmedizin - Berlin, Germany Sponsored by:
14:40 - 15:05	Coffee Break and Exhibitor Hours
Session 2
15:05 - 15:35	Bridging Biology and Clinical Care in Myelofibrosis: Addressing Anemia as a Key Unmet Medical Need Daniel Sasca, MD, University Medical Centre Mainz, Germany Sponsored by:
15:35 - 16:05	Menin Inhibition as a Pillar of Chemo Free Hematology: From Immune Activation to Resistance Biology Robert Zeiser, MD, Universitätsklinikum Freiburg, Germany The enhanced graft-vs-leukemia effect by menin inhibition Florian Perner, MD, Medizinische Hochschule Hannover, Germany MEN1 mutations as acquired resistance mechanism to menin inhibition Sponsored by:
16:10 - 16:40	From Bench to Bedside: Transforming CML Treatment with Allosteric Inhibition Oliver Hantschel, PhD, Marburg University, Germany From Molecular Insight to Targeted Therapy: The Development of Allosteric BCR::ABL1 Inhibition in CML Fabian Lang, MD, Goethe University Hospital Frankfurt, Germany Translating Innovation into Practice: Clinical Perspectives on Allosteric Inhibition Sponsored by:
16:35 - 16:45	Closing Remarks

You have the option to add this free symposium to your ISEH registration, or to only register for this free symposium.

ONLY Symposium Registraton

Add on to your registration

Trainee Workshop

New Investigators Workshop

Thursday, 27 August, 10:00 - 16:30 CEST | $90 USD

This pre-meeting workshop, offered exclusively for students (graduate, PhD, MD, etc.) and post-doctoral fellows, is a unique opportunity to present your current research to your peers and experienced ISEH faculty (posters and selected talks) and has ample opportunity to network with your peers and faculty who will become your future colleagues.

All PhD students and postdoctoral fellows are encouraged to attend and participate in the pre-meeting workshop. Participants are invited to present a poster to receive feedback from the poster judges. In addition, up to six short talks will be selected from participant abstracts submitted to the main meeting. Check out the schedule below!

Prizes will be awarded for the top short talk and posters:

Best two short talks: $125 USD
Top three posters: $100 USD each

The top short talk from the workshop will be invited to give a presentation during the main meeting program.

Be sure to select this workshop when registering for the conference to secure your spot, or add it to your existing registration. Space is limited, and last‑minute sign‑ups will not be possible.

REGISTER NOW

Program at a Glance The following is a schedule-at-a-glance of the 2026 ISEH Pre-Meeting Workshop. Schedule is subject to change.
Thursday, 27 August
10:00 - 10:30	Registration and poster set up
10:30 - 10:45	Introduction and welcome Adam Wilkinson, Pre-Meeting Workshop Chair Marlies Vanden Bempt Hannah Uckelmann
10:45 - 12:15	Short talk presentations PhD/MD Students Terri Cain, St. Jude Children's Research Hospital, USA Epigenetic Dysregulation and Niche Engagement Dysfunction of Sickle Cell Disease Hematopoietic Stem Cells Sonia Fernández Torices, German Cancer Research Center (DKFZ), Germany Long-term ex vivo Hematopoietic Stem Cell (HSC) expansion using bone-derived reinvigorating Mesenchymal Stromal Cells (rMSCs) Torben Roy, de Duve Institute, Belgium A genetically-encoded aspartate biosensor reveals two distinct leukemia populations responding differently to chemotherapy Postdoctoral Fellows Violeta Garcia-Hernandez, Unversity of Cambridge, UK SMARCA4 mutations promote chemotherapy resistance in T-acute lymphoblastic leukemia through altered chromatin remodeling Jasmin Straube, QIMR Berghofer, Australia Integrative Spatial and Single-Cell Profiling Maps Therapeutic Remodeling of the MPN Niche Charles Dussiau, EMBL and DKFZ Heidelberg, Germany Hematologic aging is heterogeneous and reflects multiple independent traits
12:15 - 13:15	Lunch and networking
13:15 - 14:00	Odd numbered posters
14:00 - 14:45	Even numbered posters
14:45 - 15:15	Break
15:15 - 16:15	Keynote Presentation - "Cultivating Creativity in Science" Ellen Rothenberg, PhD Alejo Rodríguez Fraticelli, PhD
16:15 - 16:30	Awards presentations

iPSC Symposium

2026 Symposium on “Human Pluripotent Stem Cell-Derived Hematopoiesis”

This is an event planned by another organizer and is not an official ISEH event.

This is a one-day symposium of invited speaker talks and short talks selected from abstracts. The aim of this symposium is to bring together researchers working in the fields of blood development, hPSC modeling of blood diseases and generation of hPSC-blood products for cell replacement therapies and immunotherapies. Topics will include recent advances in characterizing the ontogeny of the hematopoietic system, in generating disease models of non-malignant and malignant blood diseases and in developing cell and gene therapies using hPSC-derived cells.

LEARN MORE